Inhibition of FOSL1 overexpression in antiestrogen-resistant MCF-7 cells decreases cell growth and increases vacuolization and cell death

Steroids

Volumn 76, Issue 10-11, 2011, Pages 1063-1068

  Pennanen, Pasi T ^a   Sarvilinna, Nanna S ^a   Toimela, Tarja ^a   Ylikomi, Timo J ^a,b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

Antiestrogen; Breast cancer; Cell growth; FOSL1; Machine vision

Indexed keywords

ESTROGEN; FOS LIKE ANTIGEN 1; MATRIX METALLOPROTEINASE; MESSENGER RNA; SMALL INTERFERING RNA; TOREMIFENE; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CELL GROWTH; CELL STRUCTURE; CELL VACUOLE; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; GROWTH RATE; HUMAN; HUMAN CELL;

ANTINEOPLASTIC AGENTS, HORMONAL; BLOTTING, WESTERN; CELL DEATH; CELL LINE, TUMOR; CELL PROLIFERATION; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTROGEN RECEPTOR MODULATORS; HUMANS; PROTO-ONCOGENE PROTEINS C-FOS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TOREMIFENE; VACUOLES;

EID: 79960456819     PISSN: 0039128X     EISSN: 18785867     Source Type: Journal    
DOI: 10.1016/j.steroids.2011.04.011     Document Type: Article

References (26)

1. J.A. Dumont, A.J. Bitonti, C.D. Wallace, R.J. Baumann, E.A. Cashman, and D.E. Cross-Doersen Progression of MCF-7 breast cancer cells to antiestrogen-resistant phenotype is accompanied by elevated levels of AP-1 DNA-binding activity Cell Growth Differ 7 1996 351 359 (Pubitemid 26360774)
2. Y. Zhou, C. Yau, J.W. Gray, K. Chew, S.H. Dairkee, and D.H. Moore Enhanced NF kappa B and AP-1 transcriptional activity associated with antiestrogen resistant breast cancer BMC Cancer 7 2007 59
3. R.B. Riggins, J.P. Lan, Y. Zhu, U. Klimach, A. Zwart, and L.R. Cavalli ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer Cancer Res 68 2008 8908 8917
4. S.R. Johnston, B. Lu, G.K. Scott, P.J. Kushner, I.E. Smith, and M. Dowsett Increased activator protein-1 DNA binding and c-Jun NH2-terminal kinase activity in human breast tumors with acquired tamoxifen resistance Clin Cancer Res 5 1999 251 256 (Pubitemid 29085176)
5. R. Schiff, P. Reddy, M. Ahotupa, E. Coronado-Heinsohn, M. Grim, and S.G. Hilsenbeck Oxidative stress and AP-1 activity in tamoxifen-resistant breast tumors in vivo J Natl Cancer Inst 92 2000 1926 1934 (Pubitemid 32036923)
6. M.R. Young, and N.H. Colburn Fra-1 a target for cancer prevention or intervention Gene 379 2006 1 11 (Pubitemid 44247331)
7. K. Milde-Langosch The Fos family of transcription factors and their role in tumourigenesis Eur J Cancer 41 2005 2449 2461 (Pubitemid 41540622)
8. B. Baan, E. Pardali, P. Ten Dijke, and H. van Dam In situ proximity ligation detection of c-Jun/AP-1 dimers reveals increased levels of c-Jun/Fra1 complexes in aggressive breast cancer cell lines in vitro and in vivo Mol Cell Proteomics 9 2010 1982 1990
9. D.A. Zajchowski, M.F. Bartholdi, Y. Gong, L. Webster, H.L. Liu, and A. Munishkin Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells Cancer Res 61 2001 5168 5178 (Pubitemid 32681550)
10. K. Belguise, N. Kersual, F. Galtier, and D. Chalbos FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells Oncogene 24 2005 1434 1444 (Pubitemid 40343123)
11. V. Tkach, E. Tulchinsky, E. Lukanidin, C. Vinson, E. Bock, and V. Berezin Role of the Fos family members, c-Fos, Fra-1 and Fra-2, in the regulation of cell motility Oncogene 22 2003 5045 5054 (Pubitemid 37026402)
12. O. Kustikova, D. Kramerov, M. Grigorian, V. Berezin, E. Bock, and E. Lukanidin Fra-1 induces morphological transformation and increases in vitro invasiveness and motility of epithelioid adenocarcinoma cells Mol Cell Biol 18 1998 7095 7105 (Pubitemid 28533029)
13. A. Philips, C. Teyssier, F. Galtier, C. Rivier-Covas, J.M. Rey, and H. Rochefort FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells Mol Endocrinol 12 1998 973 985 (Pubitemid 30660665)
14. H. Nakajima, N. Mizuta, K. Sakaguchi, I. Fujiwara, M. Mizuta, and C. Furukawa Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity J Antibiot (Tokyo) 60 2007 682 689
15. A.M. Bamberger, C. Methner, B.W. Lisboa, C. Stadtler, H.M. Schulte, and T. Loning Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype Int J Cancer 84 1999 533 538
16. N. Ndlovu, C. Van Lint, K. Van Wesemael, P. Callebert, D. Chalbos, and G. Haegeman Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells Mol Cell Biol 29 2009 5488 5504
17. G. Chiappetta, A. Ferraro, G. Botti, M. Monaco, R. Pasquinelli, and E. Vuttariello FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders BMC Cancer 7 2007 17
18. Y. Song, S. Song, D. Zhang, Y. Zhang, L. Chen, and L. Qian An association of a simultaneous nuclear and cytoplasmic localization of Fra-1 with breast malignancy BMC Cancer 6 2006 298
19. N. Sarvilinna, H. Eronen, S. Miettinen, A. Vienonen, and T. Ylikomi Steroid hormone receptors and coregulators in endocrine-resistant and estrogen-independent breast cancer cells Int J Cancer 118 2006 832 840 (Pubitemid 43157658)
20. P.T. Pennanen, N.S. Sarvilinna, and T.J. Ylikomi Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models Anticancer Drugs 20 2009 51 58
21. W. Kueng, E. Silber, and U. Eppenberger Quantification of cells cultured on 96-well plates Anal Biochem 182 1989 16 19 (Pubitemid 19251274)
22. T. Toimela, H. Tahti, and T. Ylikomi Comparison of an automated pattern analysis machine vision time-lapse system with traditional endpoint measurements in the analysis of cell growth and cytotoxicity Altern Lab Anim 36 2008 313 325
23. M.W. Pfaffl A new mathematical model for relative quantification in real-time RT-PCR Nucleic Acids Res 29 2001 e45
24. K. Milde-Langosch, H. Roder, B. Andritzky, B. Aslan, G. Hemminger, and A. Brinkmann The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas Breast Cancer Res Treat 86 2004 139 152 (Pubitemid 38988017)
25. D. Gozuacik, and A. Kimchi Autophagy as a cell death and tumor suppressor mechanism Oncogene 23 2004 2891 2906 (Pubitemid 38638851)
26. D.G. DeNardo, H.T. Kim, S. Hilsenbeck, V. Cuba, A. Tsimelzon, and P.H. Brown Global gene expression analysis of estrogen receptor transcription factor cross talk in breast cancer: identification of estrogen-induced/activator protein-1-dependent genes Mol Endocrinol 19 2005 362 378 (Pubitemid 40223461)